CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancerRaymond J. Lim, Bin Liu, Jensen Abascal et al.|Cell Reports Medicine|2024Cited by 111
Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung CancerRui Li, Steven M. Dubinett, Jensen Abascal et al.|Cancer Research|2021Cited by 98
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burdenRamin Salehi‐Rad, Steven M. Dubinett, Jensen Abascal et al.|Cancer Immunology Immunotherapy|2021Cited by 24
Novel <i>Kras</i> -mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burdenRamin Salehi‐Rad, Steven M. Dubinett, Jensen Abascal et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 3
Abstract 2710: Depletion of CXCR2-dependent myeloid-derived suppressor cells (MDSCs) overcomes anti-PD-1 resistance in a murine model of LKB1-deficient non-small cell lung cancer (NSCLC) with high mutational loadRui Li, Steven M. Dubinett, Bin Liu et al.|Cancer Research|2019Cited by 1